143.07

3.60% 4.97

After Hours: 143.00 -0.07 -0.05%

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $143.07, with a volume of 2.41M. It is up +3.60% in the last 24 hours and up +20.66% over the past month. Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Previous Close:

$138.10

Open:

$142.28

24h Volume:

2.41M

Relative Volume:

1.37

Market Cap:

$9.49B

Revenue:

$409.48M

Net Income/Loss:

$-81.28M

P/E Ratio:

-107.68

EPS:

-1.3286

Net Cash Flow:

$-95.14M

1W Performance:

+13.98%

1M Performance:

+20.66%

6M Performance:

+217.86%

1Y Performance:

+428.32%

1-Day Range:

$137.08

$148.50

1-Week Range:

$120.19

$148.50

52-Week Range:

$23.30

$155.44

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1066)

Industry

Diagnostics & Research (50)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

979

Twitter

@TwistBioscience

Next Earnings Date

2026-08-03

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST vs TMO, DHR, NTRA, IQV, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	143.07	8.43B	409.48M	-81.28M	-95.14M	-1.3286
TMO Thermo Fisher Scientific Inc	648.43	225.48B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	208.36	140.70B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	345.34	47.41B	2.50B	-226.32M	71.51M	-1.6412
IQV Iqvia Holdings Inc	268.82	43.09B	16.63B	1.39B	2.12B	8.0674
A Agilent Technologies Inc	153.69	41.42B	7.23B	1.41B	1.09B	4.979

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-25	Initiated	Stephens	Overweight
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Sep 11, 2026

Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia - investing.com

Sep 11, 2026

Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia By Investing.com - Investing.com Australia

Sep 11, 2026

Sep 10, 2026

Twist Bioscience HR SVP Paula Green Sells Shares to Cover RSU Tax Withholding - Kalkine Media

Sep 10, 2026

Sep 09, 2026

TWST Initiated Coverage by BWS Financial -- Current Rating: Sell - GuruFocus

Sep 09, 2026

BWS Financial initiates Twist Bioscience stock with sell rating - investing.com

Sep 09, 2026

TWST Initiates Coverage On UBS -- Rating Set at Neutral with $144 Target - GuruFocus

Sep 09, 2026

BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com India

Sep 09, 2026

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - BioSpace

Sep 09, 2026

Sep 08, 2026

After $14M August sale, Twist Bioscience (NASDAQ: TWST) investor plans another stock sale - Stock Titan

Sep 08, 2026

Officer at Twist Bioscience (TWST) preps 907-share sale - Stock Titan

Sep 08, 2026

Twist Bioscience (NASDAQ: TWST) insider to sell shares, including stock to cover taxes - Stock Titan

Sep 08, 2026

Twist Bioscience (NASDAQ: TWST) officer plans about $50K stock sale - Stock Titan

Sep 08, 2026

Cathie Wood’s ARK reveals stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan

Sep 08, 2026

Claim your share of the $17 million Twist Bioscience securities class action settlement - claimdepot.com

Sep 08, 2026

An investor holds voting power over 8.8M Twist Bioscience (TWST) shares - Stock Titan

Sep 08, 2026

Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand - Yahoo Finance

Sep 08, 2026

Twist Bioscience (NASDAQ: TWST) HR chief reports tax-driven stock sale - Stock Titan

Sep 08, 2026

Sep 06, 2026

About Twist Bioscience Corporation • Robinhood Token - Coinbase

Sep 06, 2026

Sep 04, 2026

Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience - investing.com

Sep 04, 2026